The Cubs have signed former All-Star closer Liam Hendriks to a Minor League deal, boosting their bullpen depth. At 37, Hendriks has faced significant health challenges recently, including a battle with non-Hodgkins lymphoma and multiple injuries that have limited his playtime. Despite logging only 18 2/3 innings over the last three years, he previously dominated as a reliever, leading MLB in fWAR from 2019-22. The Cubs have not yet confirmed the deal, but if Hendriks can regain his form, he could be a valuable asset. This low-risk move may pay off significantly for the franchise.

By the Numbers
  • Hendriks led all relievers with a collective 9.5 fWAR from 2019-22.
  • He averaged 13.5 strikeouts per nine innings during his peak years.
Yes, But

Hendriks' recent medical history raises concerns about his ability to perform consistently after missing significant time due to cancer treatment and injuries. His track record before health setbacks is impressive, but his lengthy absence casts doubt on his current effectiveness.

State of Play
  • Hendriks is aiming for a comeback in his 15th MLB season despite limited recent appearances.
  • The Cubs are betting on his experience to bolster their bullpen for the upcoming season.
What's Next

If Hendriks can successfully complete his rehab and regain form, he may factor into the Cubs' bullpen plans later in the season. The team's competitive position will influence how they utilize him, depending on the state of their pitching staff.

Bottom Line

The Cubs' investment in Liam Hendriks is a calculated risk that might provide high returns if he can stay healthy and perform near his previous elite level, adding substantial value to the roster.